15 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2026 | $282M | $10M | 28.5% | 5.9% | $15M | $20M | $10M |
| 2025 | $240M | $11M | 28.6% | 7.4% | $13M | $39M | $15M |
| 2024 | $204M | $19M | 25.5% | 9.0% | $15M | — | $23M |
| 2023 | $219M | $738000 | 16.2% | 2.4% | -$8M | — | $8M |
| 2022 | $169M | -$6M | 14.3% | -1.5% | -$10M | — | $4M |
| 2021 | $147M | -$4M | 16.3% | -0.9% | -$1M | — | $5M |
| 2020 | $148M | -$5M | 15.9% | -1.6% | $2M | $5M | $4M |
| 2019 | $147M | $2M | 17.3% | 1.4% | -$2M | $97000 | $11M |
| 2018 | $158M | $5M | 20.3% | 6.3% | -$212000 | $1M | $10M |
| 2017 | $139M | $5M | 19.2% | 4.7% | $9M | $2M | $13M |
| 2016 | $129M | $4M | 18.4% | 4.4% | $5M | $3M | $5M |
| 2015 | — | $4M | — | — | — | $4M | $3M |
| 2014 | — | $4M | — | — | — | $4M | $6M |
| 2013 | — | $3M | — | — | $1M | $3M | $6M |
| 2012 | — | $1M | — | — | $5M | $10M | $6M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Apr '26 | $71M | $3M | 29.8% | 7.3% | $5M | $20M | $10M |
| Jan '26 | $69M | $692000 | 26.7% | 3.7% | $11M | $21M | $8M |
| Oct '25 | $70M | $2M | 28.1% | 5.9% | -$6M | $35M | $13M |
| Jul '25 | $71M | $3M | 29.4% | 6.8% | $5M | $37M | $19M |
| Apr '25 | $77M | $5M | 31.2% | 11.0% | $9M | $39M | $15M |
| Jan '25 | $67M | $1M | 27.4% | 3.3% | -$3M | $38M | $9M |
| Oct '24 | $48M | $3M | 29.2% | 9.3% | $8M | — | $26M |
| Jul '24 | $48M | $2M | 25.8% | 5.3% | -$1M | — | $24M |
| Apr '24 | $57M | $11M | 25.8% | 9.8% | $166000 | — | $23M |
| Jan '24 | $47M | $3M | 25.7% | 8.1% | $9M | — | $21M |
| Oct '23 | $50M | $3M | 26.7% | 10.1% | -$518000 | — | $14M |
| Jul '23 | $50M | $2M | 23.9% | 7.6% | $7M | — | $13M |
| Apr '23 | $54M | $1M | 19.2% | 5.0% | -$3M | — | $8M |
| Jan '23 | $61M | $723000 | 17.0% | 3.8% | -$4M | — | $13M |
| Oct '22 | $55M | -$243000 | 15.9% | 1.4% | -$5M | — | $9M |
| Jul '22 | $50M | -$747000 | 12.4% | -0.8% | $3M | — | $14M |
| Apr '22 | $50M | -$362000 | 18.8% | 4.5% | -$7M | — | $4M |
| Jan '22 | $41M | -$1M | 13.8% | -2.1% | $5M | — | $5M |
| Oct '21 | $39M | -$3M | 9.2% | -7.4% | -$5M | — | $5M |
| Jul '21 | $39M | -$1M | 14.4% | -2.8% | -$2M | — | $5M |
How the market has priced KEQU against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, KEWAUNEE SCIENTIFIC CORP /DE/'s revenue has grown 13.8% per year. These are computed facts, not advice.
As of FY2026, KEWAUNEE SCIENTIFIC CORP /DE/ reported $20M of total debt against $10M of cash; operating income covered interest expense 4.3×.
In FY2026, gross margin was 28.5%, operating margin 5.9%, and net margin 3.4%.
As of Jun '26, KEWAUNEE SCIENTIFIC CORP /DE/ traded at a price-to-earnings ratio of about 10.3× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.